semaglutide news november 28 2025 The Risks of Compounded Products Weight-loss drugs becoming better value

Patient-centered decision-making, incorporating individual preferences and treatment goals, guides optimal long-term therapy management

Animal reproduction studies, required for FDA approval, have shown some findings that warrant consideration

It wasn't until 2023 that the FDA issued a Black Box warning for potential risks of thyroid cancer along with several mandated label warnings that highlighted a potential risk for kidney failure and pancreatitis when taking Ozempic

The European Medicines Agencys Pharmacovigilance Risk Assessment Committee said other research it has reviewed so far is not strong enough to support a link between Ozempic and the eye disease

Louis nursing home abuse attorney from TorHoerman Law today for a free consultation to discuss your legal options